We study the causal effect of subsidized R&D collaboration on innovation performance of small and medium-sized enterprises (SMEs). In particular, we make use of a randomized controlled trial to analyze the effect of a nationwide innovation voucher scheme in the United Kingdom that grants SMEs...

Inter-departmental innovation collaboration facilitates innovation performance. At the same time, it has been identified as source of increased coordination costs. Using organizational information processing theory, this paper builds and tests hypotheses on the costs and benefits of...

Using firm-level data from the German manufacturing sector, we estimate a dynamic, structural model of the firm’s decision to invest in R&D and quantify the cost and longrun benefit of this investment. The model incorporates and quantifies linkages between the firm’s R&D investment, product...

Um den gesellschaftlichen Nutzen pharmazeutischer Innovationen abzuschätzen, bedarf es adäquater Beurteilungskriterien. Nach einem empirischen Abriß über die Entwicklung der Arzneimittelausgaben erörtern die Autoren die beurteilungsrelevanten gesamtwirtschaftlichen Ziele. Auf...